NASDAQ
Bluejay Diagnostics, Inc. (BJDX) has a free cash flow growth of 1.25% as of Friday, May 29, 2026. This represents a 118.29% increase compared to its 12-month average of -6.86%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.